| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 20,5 M € | +22.2% | 16,8 M € | +0.4% | 16,7 M € | +3.0% | 16,3 M € | +10.1% | 14,8 M € | +30.1% | 11,4 M € | +25.1% | 9,1 M € | +20.0% | 7,6 M € | +46.8% | 5,2 M € | -5.6% | 5,5 M € | +2.8% | 5,3 M € | -34.8% | 8,1 M € | +45.2% | 5,6 M € | -4.9% | 5,9 M € | +15.8% | 5,1 M € | -0.2% | 5,1 M € | +3.3% | 4,9 M € | +5.9% | 4,7 M € | |
| EBITDA | 674,7 k € | +32.9% | 507,5 k € | -0.2% | 508,3 k € | +3.2% | 492,7 k € | +10.0% | 448,1 k € | +37.6% | 325,6 k € | -2.0% | 332,3 k € | -14.7% | 389,8 k € | +23.2% | 316,5 k € | -12.0% | 359,6 k € | -18.3% | 439,9 k € | +819.4% | 47,8 k € | -19.9% | 59,7 k € | +12613.5% | 469,9 € | -99.0% | 47,4 k € | -57.0% | 110,1 k € | -58.3% | 263,8 k € | -41.2% | 448,8 k € | |
| Operating profit | 674,7 k € | +32.9% | 507,5 k € | -0.2% | 508,3 k € | +3.2% | 492,7 k € | +10.0% | 448,1 k € | +37.6% | 325,6 k € | -2.0% | 332,3 k € | -28.4% | 464,3 k € | +52.4% | 304,6 k € | -12.5% | 348,0 k € | -12.7% | 398,4 k € | +1274.9% | 29,0 k € | -53.5% | 62,3 k € | +1037.1% | -6,6 k € | -145.3% | 14,7 k € | -85.1% | 98,4 k € | -61.2% | 253,7 k € | -44.2% | 454,5 k € | |
| Profit/loss | 584,8 k € | +23.7% | 472,8 k € | +25.1% | 378,1 k € | +10.3% | 342,6 k € | +8.5% | 315,9 k € | +61.6% | 195,4 k € | +35.3% | 144,4 k € | -37.7% | 231,9 k € | +48.6% | 156,0 k € | -13.9% | 181,2 k € | -41.5% | 309,6 k € | +189.2% | -347,2 k € | -1126.5% | 33,8 k € | +309.3% | -16,2 k € | -354.8% | 6,3 k € | -90.1% | 64,1 k € | -59.5% | 158,5 k € | -45.7% | 292,0 k € | |
| Equity | 662,8 k € | +749.4% | 78,0 k € | -94.4% | 1,4 M € | +36.8% | 1,0 M € | +50.1% | 684,5 k € | +85.7% | 368,6 k € | -77.7% | 1,7 M € | +9.6% | 1,5 M € | +18.1% | 1,3 M € | +13.9% | 1,1 M € | +19.3% | 940,9 k € | +49.0% | 631,4 k € | -35.5% | 978,5 k € | +3.6% | 944,7 k € | -1.7% | 960,9 k € | -9.9% | 1,1 M € | +6.4% | 1,0 M € | +18.8% | 844,5 k € | |
| Total assets | 5,5 M € | -7.8% | 6,0 M € | +10.0% | 5,4 M € | +15.8% | 4,7 M € | +11.5% | 4,2 M € | +49.6% | 2,8 M € | +11.9% | 2,5 M € | +3.0% | 2,4 M € | -5.2% | 2,6 M € | +16.1% | 2,2 M € | +13.0% | 2,0 M € | +1.2% | 1,9 M € | -4.3% | 2,0 M € | +2.7% | 2,0 M € | +24.0% | 1,6 M € | +19.0% | 1,3 M € | -6.6% | 1,4 M € | -6.4% | 1,5 M € | |
| Cash | — | — | — | — | — | — | 1,4 M € | -8.0% | 1,5 M € | +47.9% | 1,0 M € | +196.2% | 344,3 k € | -21.7% | 439,4 k € | +256.5% | 123,3 k € | -52.9% | 262,0 k € | +17.1% | 223,7 k € | +11.3% | 201,0 k € | +83.6% | 109,4 k € | -37.5% | 175,0 k € | +44.5% | 121,1 k € | |||||||
| Debts | 4,9 M € | -17.8% | 5,9 M € | +46.4% | 4,0 M € | +9.9% | 3,7 M € | +4.0% | 3,5 M € | +44.3% | 2,4 M € | +183.4% | 862,7 k € | -7.6% | 933,6 k € | -28.2% | 1,3 M € | +18.3% | 1,1 M € | +12.1% | 981,2 k € | -12.9% | 1,1 M € | +7.1% | 1,1 M € | +2.0% | 1,0 M € | +63.2% | 631,4 k € | +132.9% | 271,2 k € | -36.0% | 423,5 k € | -36.2% | 663,7 k € | |
| Staff | 15,9 | 15,1 | 13,3 | 12,1 | 11,7 | 11,5 | 10,5 | 10,6 | 10,3 | 11 | 10,1 | 5,6 | 7,4 | 7,9 | 7,9 | 8 | 7,9 | 7 | ||||||||||||||||||
Public limited company · Herentals · incorporated on 16/03/1971 · 15,9 ETP
Public limited company profitable and well capitalised. Cash position declining (-8.0%).
Solid counterparty for a standard engagement.
DECHRA VETERINARY PRODUCTS is a Public limited company incorporated in 1971. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Herentals. It employs on average 15,9 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette